Back to top

Wells Fargo Gives a Buy Rating to Kiniksa Pharmaceuticals (KNSA)

In a report released today, Eva Fortea Verdejo from Wells Fargo assigned a Buy rating to Kiniksa Pharmaceuticals, with a price target of $87.00. Fo...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Kiniksa Pharmaceuticals International, plc (KNSA)